ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email!
Oppositional Defiant Disorder (ODD) Global Clinical Trials Review, H2, 2014 Published on July 2014
Report Summary Oppositional Defiant Disorder (ODD) Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, 'Oppositional Defiant Disorder (ODD) Global Clinical Trials Review, H2, 2014" provides data on the Oppositional Defiant Disorder (ODD) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Oppositional Defiant Disorder (ODD). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Oppositional Defiant Disorder (ODD). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Content Table of Contents Table of Contents 2 Introduction 5 Oppositional Defiant Disorder (ODD) 5 Report Guidance 5
Oppositional Defiant Disorder (ODD) Global Clinical Trials Review, H2, 2014 (From Issuu)
Page 1/6
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Countries Contributing to Clinical Trials in Asia-Pacific 9 Top Five Countries Contributing to Clinical Trials in Europe 10 Top Countries Contributing to Clinical Trials in North America 11 Top Countries Contributing to Clinical Trials in Middle East and Africa 12 Clinical Trials by G7 Countries: Proportion of Oppositional Defiant Disorder (ODD) to Central Nervous System Clinical Trials 13 Clinical Trials by Phase in G7 Countries 14 Clinical Trials in G7 Countries by Trial Status 15 Clinical Trials by Phase 16 In Progress Trials by Phase 17 Clinical Trials by Trial Status 18 Clinical Trials by End Point Status 19 Subjects Recruited Over a Period of Time 20 Clinical Trials by Sponsor Type 21 Prominent Sponsors 22 Top Companies Participating in Oppositional Defiant Disorder (ODD) Therapeutics Clinical Trials 23 Prominent Drugs 24 Clinical Trial Profiles 25 Clinical Trial Overview of Top Companies 25 Eli Lilly and Company 25 Clinical Trial Overview of Eli Lilly and Company 25 Janssen Global Services, LLC 26 Clinical Trial Overview of Janssen Global Services, LLC 26 Clinical Trial Overview of Top Institutes / Government 27 University of Pittsburgh 27 Clinical Trial Overview of University of Pittsburgh 27 The University of New South Wales 28 Clinical Trial Overview of The University of New South Wales 28 New York State Psychiatric Institute 29 Clinical Trial Overview of New York State Psychiatric Institute 29 German Research Foundation 30 Clinical Trial Overview of German Research Foundation 30 Stony Brook University 31 Clinical Trial Overview of Stony Brook University 31 University of Cologne 32 Clinical Trial Overview of University of Cologne 32 University Hospital Freiburg 33 Clinical Trial Overview of University Hospital Freiburg 33 Ohio State University 34 Clinical Trial Overview of Ohio State University 34 UMC Utrecht Holding BV 35 Clinical Trial Overview of UMC Utrecht Holding BV 35 Johann Wolfgang Goethe University Hospitals 36 Clinical Trial Overview of Johann Wolfgang Goethe University Hospitals 36 Five Key Clinical Profiles 37 Appendix 61 Abbreviations 61
Oppositional Defiant Disorder (ODD) Global Clinical Trials Review, H2, 2014 (From Issuu)
Page 2/6
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! Definitions 61 Research Methodology 62 Secondary Research 62 About GlobalData 63 Contact Us 63 Disclaimer 63 Source 63 List of Tables
Oppositional Defiant Disorder (ODD) Therapeutics, Global, Clinical Trials by Region, 2014* 6 Oppositional Defiant Disorder (ODD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7 Oppositional Defiant Disorder (ODD) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8 Oppositional Defiant Disorder (ODD) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9 Oppositional Defiant Disorder (ODD) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10 Oppositional Defiant Disorder (ODD) Therapeutics Clinical Trials, North America, Top Countries, 2014* 11 Oppositional Defiant Disorder (ODD) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12 Proportion of Oppositional Defiant Disorder (ODD) to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13 Oppositional Defiant Disorder (ODD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14 Oppositional Defiant Disorder (ODD) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15 Oppositional Defiant Disorder (ODD) Therapeutics, Global, Clinical Trials by Phase, 2014* 16 Oppositional Defiant Disorder (ODD) Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 17 Oppositional Defiant Disorder (ODD) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18 Oppositional Defiant Disorder (ODD) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 19 Oppositional Defiant Disorder (ODD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 20 Oppositional Defiant Disorder (ODD) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 21 Oppositional Defiant Disorder (ODD) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 22 Oppositional Defiant Disorder (ODD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 23 Oppositional Defiant Disorder (ODD) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 24 Oppositional Defiant Disorder (ODD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 25 Oppositional Defiant Disorder (ODD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Global Services, LLC, 2014* 26 Oppositional Defiant Disorder (ODD) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014* 27 Oppositional Defiant Disorder (ODD) Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of New South Wales, 2014* 28 Oppositional Defiant Disorder (ODD) Therapeutics Clinical Trials Market, Global, Clinical Trials by New York State Psychiatric Institute, 2014* 29 Oppositional Defiant Disorder (ODD) Therapeutics Clinical Trials Market, Global, Clinical Trials by German Research Foundation, 2014* 30 Oppositional Defiant Disorder (ODD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Stony Brook University, 2014* 31 Oppositional Defiant Disorder (ODD) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cologne, 2014* 32 Oppositional Defiant Disorder (ODD) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Freiburg, 2014* 33 Oppositional Defiant Disorder (ODD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Ohio State University, 2014* 34 Oppositional Defiant Disorder (ODD) Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht Holding BV, 2014* 35 Oppositional Defiant Disorder (ODD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Johann Wolfgang Goethe University Hospitals, 2014* 36
Oppositional Defiant Disorder (ODD) Global Clinical Trials Review, H2, 2014 (From Issuu)
Page 3/6
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! List of Figures
Oppositional Defiant Disorder (ODD) Therapeutics, Global, Clinical Trials by Region (%), 2014* 6 Oppositional Defiant Disorder (ODD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7 Oppositional Defiant Disorder (ODD) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8 Oppositional Defiant Disorder (ODD) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9 Oppositional Defiant Disorder (ODD) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10 Oppositional Defiant Disorder (ODD) Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11 Proportion of Oppositional Defiant Disorder (ODD) to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13 Oppositional Defiant Disorder (ODD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14 Oppositional Defiant Disorder (ODD) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15 Oppositional Defiant Disorder (ODD) Therapeutics, Global, Clinical Trials by Phase (%), 2014* 16 Oppositional Defiant Disorder (ODD) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 17 Oppositional Defiant Disorder (ODD) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18 Oppositional Defiant Disorder (ODD) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 19 Oppositional Defiant Disorder (ODD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 20 Oppositional Defiant Disorder (ODD) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 21 Oppositional Defiant Disorder (ODD) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 22 Oppositional Defiant Disorder (ODD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 23 Oppositional Defiant Disorder (ODD) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 24 GlobalData Methodology 62
Oppositional Defiant Disorder (ODD) Global Clinical Trials Review, H2, 2014 (From Issuu)
Page 4/6
Find Industry reports, Company profiles and Market Statistics
ReportLinker
>> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: ƒ ƒ
Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information Please verify that the product information is correct and select the format(s) you require. Oppositional Defiant Disorder (ODD) Global Clinical Trials Review, H2, 2014
Product Formats Please select the product formats and the quantity you require. 1 User License--USD 2 500.00
Quantity: _____
Site License--USD 5 000.00
Quantity: _____
Corporate License--USD 7 500.00
Quantity: _____
Contact Information Please enter all the information below in BLOCK CAPITALS
Title:
Mr
Mrs
Dr
Miss
Ms
Prof
First Name:
_____________________________ Last Name: __________________________________
Email Address:
__________________________________________________________________________
Job Title:
__________________________________________________________________________
Organization:
__________________________________________________________________________
Address:
__________________________________________________________________________
City:
__________________________________________________________________________
Postal / Zip Code:
__________________________________________________________________________
Country:
__________________________________________________________________________
Phone Number:
__________________________________________________________________________
Fax Number:
__________________________________________________________________________
Oppositional Defiant Disorder (ODD) Global Clinical Trials Review, H2, 2014 (From Issuu)
Page 5/6
Find Industry reports, Company profiles and Market Statistics
ReportLinker
>> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card
Card Number: ______________________________________________
Expiry Date
__________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer
Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check
UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms
Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
Oppositional Defiant Disorder (ODD) Global Clinical Trials Review, H2, 2014 (From Issuu)
Page 6/6